MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Change in Cash
-$16,784K
Free Cash flow
-$32,522K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Proceeds from issuance of common...
Maturities of marketable securit...
Proceeds from issuance of pre-fu...
Others
Negative Cash Flow Breakdown
Purchases of marketable securiti...
Repurchase of common stock, incl...
Prepaid expenses and other asset...
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net loss
-45,637
-33,685
-25,559
-26,130
Depreciation expense
260
274
272
280
Accretion income on marketable securities
340
292
424
337
Stock-based compensation expense
12,368
3,824
3,282
3,688
Other non-cash items
19
0
0
0
Non-cash lease expense
423
412
402
392
Prepaid expenses and other assets
1,417
-1,727
-2,683
1,534
Other long-term assets
622
46
194
92
Accounts payable
-326
1,024
-430
602
Accrued expenses and other liabilities
3,168
-2,745
-124
3,345
Operating lease liabilities
-397
-386
-377
-358
Net cash used in operating activities
-32,501
-29,893
-20,469
-20,144
Purchases of property and equipment
21
102
176
45
Purchases of marketable securities
256,014
-
0
73,974
Maturities of marketable securities
30,000
55,000
30,000
30,000
Net cash provided by (used in) investing activities
-226,035
54,898
29,824
-44,019
Proceeds from exercise of stock options
80
56
0
1,008
Proceeds from exercise of warrants
0
123
-
-
Proceeds from issuance of common stock from follow-on offering, net of issuance costs
259,384
-
0
0
Proceeds from issuance of pre-funded warrants from follow-on offering, net of issuance costs
21,381
-
0
0
Proceeds from issuance of common stock warrants from follow-on offering, net of issuance costs
0
-
0
0
Proceeds from issuance of common stock under atm facility, net of issuance costs
-
-
2,767
3,287
Repurchase of common stock, including transaction costs
39,093
-
-
-
Proceeds from espp purchases
0
121
0
68
Net cash provided by financing activities
241,752
300
2,767
4,363
Net increase in cash, cash equivalents and restricted cash
-16,784
25,305
12,122
-59,800
Effect of exchange rate changes on cash and cash equivalents
-173
-27
-160
-26
Cash, cash equivalents and restricted cash at beginning of period
85,561
60,283
48,321
32,461
Cash, cash equivalents and restricted cash at end of period
68,604
85,561
60,283
48,321
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Proceeds from issuance of
common stock from...
$259,384K
(457.61%↑ Y/Y)
Proceeds from issuance of
pre-funded warrants from...
$21,381K
(51.04%↑ Y/Y)
Proceeds from exercise of
stock options
$80K
(3900.00%↑ Y/Y)
Net cash provided by
financing activities
$241,752K
(245.24%↑ Y/Y)
Canceled cashflow
$39,093K
Net increase in
cash, cash...
-$16,784K
(-122.18%↓ Y/Y)
Canceled cashflow
$241,752K
Maturities of marketable
securities
$30,000K
(-50.00%↓ Y/Y)
Stock-based compensation
expense
$12,368K
(68.34%↑ Y/Y)
Accrued expenses and
other liabilities
$3,168K
(248.13%↑ Y/Y)
Non-cash lease expense
$423K
(-44.12%↓ Y/Y)
Depreciation expense
$260K
(-54.94%↓ Y/Y)
Other non-cash items
$19K
(-29.63%↓ Y/Y)
Repurchase of common stock,
including transaction...
$39,093K
Net cash provided by
(used in) investing...
-$226,035K
(-553.98%↓ Y/Y)
Canceled cashflow
$30,000K
Net cash used in
operating activities
-$32,501K
(26.35%↑ Y/Y)
Canceled cashflow
$16,238K
Purchases of marketable
securities
$256,014K
(2464.24%↑ Y/Y)
Purchases of property and
equipment
$21K
(-90.71%↓ Y/Y)
Net loss
-$45,637K
(16.27%↑ Y/Y)
Prepaid expenses and
other assets
$1,417K
(149.17%↑ Y/Y)
Other long-term
assets
$622K
(286.79%↑ Y/Y)
Operating lease
liabilities
-$397K
(39.57%↑ Y/Y)
Accretion income on
marketable securities
$340K
(-56.69%↓ Y/Y)
Accounts payable
-$326K
(67.98%↑ Y/Y)
Buy us a coffee
Aura Biosciences, Inc. (AURA)
Aura Biosciences, Inc. (AURA)